| Stage | RGCO | % of rev | EML | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $27M | 100.00% | $62M | 100.00% | EML ×2.27 |
| Gross profit | $11M | 39.92% | $13M | 20.63% | RGCO +19.3pp |
| Operating income | $7M | 26.85% | $2M | 2.68% | RGCO +24.2pp |
| Pre-tax income | $7M | 25.20% | $8M | 12.14% | RGCO +13.1pp |
| Net income | $5M | 19.31% | $6M | 9.14% | RGCO +10.2pp |
| Stage | RGCO | EML | Gap · A − B |
|---|---|---|---|
| Revenue | $27M100.00% | $62M100.00% | EML ×2.27 |
| Gross profit | 39.92%$11M | 20.63%$13M | RGCO +19.3pp |
| Operating income | 26.85%$7M | 2.68%$2M | RGCO +24.2pp |
| Pre-tax income | 25.20%$7M | 12.14%$8M | RGCO +13.1pp |
| Net income |
| 19.31%$5M |
| 9.14%$6M |
| RGCO +10.2pp |
No disclosed counterparties: EML.
None